Literature DB >> 17429032

Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.

Martin H de Borst1, Sander H Diks, Juliane Bolbrinker, Mark W Schellings, Mario B A van Dalen, Maikel P Peppelenbosch, Reinhold Kreutz, Yigal M Pinto, Gerjan Navis, Harry van Goor.   

Abstract

Regulation of protein kinase activities is crucial in both physiology and disease, but analysis is hampered by the multitude and complexity of kinase networks. We used novel peptide array chips containing 1,152 known kinase substrate sequences to profile different kinase activities in renal lysates from homozygous Ren2 rats, a model characterized by hypertension and angiotensin II (ANG II)-mediated renal fibrosis, compared with Sprague-Dawley (SD) control rats and Ren2 rats treated with an angiotensin-converting enzyme inhibitor (ACEi). Five-wk-old homozygous Ren2 rats were left untreated or treated with the ACEi ramipril (1 mg.kg(-1).day(-1)) for 4 wk; age-matched SD rats served as controls (n = 5 each). Peptide array chips were incubated with renal cortical lysates in the presence of radioactively labeled ATP. Radioactivity incorporated into the substrate motifs was measured to quantify kinase activity. A number of kinases with modulated activities, which might contribute to renal damage, were validated by Western blotting, immunoprecipitation, and immunohistochemistry. Relevant kinases identified by the peptide array and confirmed using conventional techniques included p38 MAP kinase and PDGF receptor-beta, which were increased in Ren2 and reversed by ACEi. Furthermore, insulin receptor signaling was reduced in Ren2 compared with control rats, and G protein-coupled receptor kinase (GRK) activity decreased in Ren2 + ACEi compared with untreated Ren2 rats. Array-based profiling of tissue kinase activities in ANG II-mediated renal damage provides a powerful tool for identification of relevant kinase pathways in vivo and may lead to novel strategies for therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429032     DOI: 10.1152/ajprenal.00367.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Dissecting protein function and signaling using protein microarrays.

Authors:  Alejandro Wolf-Yadlin; Mark Sevecka; Gavin MacBeath
Journal:  Curr Opin Chem Biol       Date:  2009-08-05       Impact factor: 8.822

Review 2.  Deciphering enzyme function using peptide arrays.

Authors:  Alexandra Thiele; Gabriele I Stangl; Mike Schutkowski
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

3.  Phosphoproteomic analysis of AT1 receptor-mediated signaling responses in proximal tubules of angiotensin II-induced hypertensive rats.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Kidney Int       Date:  2011-06-22       Impact factor: 10.612

4.  Widespread deregulation of phosphorylation-based signaling pathways in multiple myeloma cells: opportunities for therapeutic intervention.

Authors:  Gwenny Manel Fuhler; Sander Henricus Diks; Maikel Petrus Peppelenbosch; William Garrow Kerr
Journal:  Mol Med       Date:  2011-04-28       Impact factor: 6.354

Review 5.  Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design.

Authors:  Matthijs Luxen; Matijs van Meurs; Grietje Molema
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

6.  Divergent immune responses to Mycobacterium avium subsp. paratuberculosis infection correlate with kinome responses at the site of intestinal infection.

Authors:  Pekka Määttänen; Brett Trost; Erin Scruten; Andrew Potter; Anthony Kusalik; Philip Griebel; Scott Napper
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

7.  Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.

Authors:  Andrea Tuettenberg; Susanne A Hahn; Johanna Mazur; Aslihan Gerhold-Ay; Jetse Scholma; Iris Marg; Alexander Ulges; Kazuki Satoh; Tobias Bopp; Jos Joore; Helmut Jonuleit
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.